CBER Director Peter Marks at the 2024 Jefferies London Healthcare Conference (Ayisha Sharma for Endpoints News)
November 21, 2024 10:46 AM ESTUpdated 12:57 PM
Pharma

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Ayisha Sharma

News Reporter

LON­DON — The FDA’s top leader of vac­cines and bi­o­log­ics said Thurs­day he is not plan­ning to leave his role in light of the in­com­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times